In parallel with the above experiments, TLR4/MyD88 expression was assessed in undifferentiated and differentiated embryonal carcinoma cells to provide further evidence of the cancer stem cell hypothesis in ovarian cancer. This evidence concerns the gene MYD88 and ovarian cancer.